News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Bio-Rad Laboratories, Inc. And Integrated DNA Technologies Collaborate To Develop Experimentally Validated siRNA Duplexes
July 13, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bio-Rad Laboratories, Inc. (AMEX: BIO) and (AMEX: BIOb), and Integrated DNA Technologies, Inc. (IDT), today announced a collaborative agreement to develop RNA interference (RNAi) tool sets for life science researchers.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Bio-Rad Laboratories, Inc.
MORE ON THIS TOPIC
Funding
China’s Corxel Nabs $287M Series D1 to Bankroll GLP-1 Pill
January 23, 2026
·
1 min read
·
Tristan Manalac
Vaccines
Moderna Won’t Run Phase III Vaccine Trials as Skepticism Grows in US: Bloomberg
January 23, 2026
·
2 min read
·
Tristan Manalac
Cancer
BMS Bets $850M on Janux’s Tumor-Activated Drugs, Deepening Cancer Investments
January 22, 2026
·
2 min read
·
Tristan Manalac
Insights
From Sound Bites to Signals: Editors Parse Executive and Investor Chatter at JPM
January 22, 2026
·
1 min read
·
Jennifer Smith-Parker
